SCI Pharmtech, Inc.: peers
SCI Pharmtech, Inc. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
Unicocell Biomed: the market cap on file is more than 60 days old or a last known value (no market-data feed for its exchange yet), so its valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | SCI Pharmtech, Inc.base 4119.TW · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Formosa Laboratories, Inc. 4746.TW · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Liwanli Innovation Co., Ltd. 3054.TW · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Orient Pharma Co., Ltd. 4166.TWO · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Alar Pharmaceuticals Inc. 6785.TWO · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Orient EuroPharma Co., Ltd. 4120.TWO · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Unicocell Biomed 6539.TWO · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Standard Chem & Pharm 1720.TW · 🇹🇼 TW Percentile in Healthcare Percentile in Taiwan | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $172 MNov 19, 2026 · Market data2nd of 8 | $150 MNov 19, 2026 · Market data3rd of 8 | $149 MNov 19, 2026 · Market data4th of 8 | $147 MNov 19, 2026 · Market data5th of 8 | $135 MNov 19, 2026 · Market data6th of 8 | $117 MNov 19, 2026 · Market data7th of 8 | $97 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one8th of 8 | $326 MNov 19, 2026 · Market data1st of 8 | $148 M8 ranked |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = SCI Pharmtech, Inc.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Formosa Laboratories, Inc.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Liwanli Innovation Co., Ltd.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Orient Pharma Co., Ltd.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Alar Pharmaceuticals Inc.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Orient EuroPharma Co., Ltd.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Unicocell Biomed: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Standard Chem & Pharm: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close.
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Fewer than two years of revenue are on file for these companies.
Rank in the group
Ranks need two fiscal years with the figure for at least two of these companies.
Suggested peers of SCI Pharmtech, Inc.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Formosa Laboratories, Inc.4746.TW · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $150 M market cap against $172 M · Same country: TaiwanMarket cap $150 M (Nov 19, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Liwanli Innovation Co., Ltd.3054.TW · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $149 M market cap against $172 M · Same country: TaiwanMarket cap $149 M (Nov 19, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Orient Pharma Co., Ltd.4166.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $147 M market cap against $172 M · Same country: TaiwanMarket cap $147 M (Nov 19, 2026)94 of 100 (industry or sector 50 + size 29 + country 15)In the group
- Alar Pharmaceuticals Inc.6785.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $135 M market cap against $172 M · Same country: TaiwanMarket cap $135 M (Nov 19, 2026)93 of 100 (industry or sector 50 + size 28 + country 15)In the group
- Orient EuroPharma Co., Ltd.4120.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $117 M market cap against $172 M · Same country: TaiwanMarket cap $117 M (Nov 19, 2026)92 of 100 (industry or sector 50 + size 28 + country 15)In the group
- Unicocell Biomed6539.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $97 M market cap against $172 M · Same country: TaiwanMarket cap $97 M (last known, Jan 5, 2024)91 of 100 (industry or sector 50 + size 26 + country 15)In the group
- Standard Chem & Pharm1720.TW · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $326 M market cap against $172 M · Same country: TaiwanMarket cap $326 M (Nov 19, 2026)91 of 100 (industry or sector 50 + size 26 + country 15)In the group
- Foresee Pharmaceuticals Co., Ltd.6576.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $331 M market cap against $172 M · Same country: TaiwanMarket cap $331 M (Nov 19, 2026)91 of 100 (industry or sector 50 + size 26 + country 15)+ Add
- Grape King Bio Ltd1707.TW · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $338 M market cap against $172 M · Same country: TaiwanMarket cap $338 M (Nov 19, 2026) · revenue $324 M (year to December 2021)91 of 100 (industry or sector 50 + size 26 + country 15)+ Add
- Anxo Pharmaceutical Co., Ltd.6677.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $87 M market cap against $172 M · Same country: TaiwanMarket cap $87 M (last known, Jan 5, 2024)91 of 100 (industry or sector 50 + size 26 + country 15)+ Add
- Maywufa Company Ltd.1731.TW · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $86 M market cap against $172 M · Same country: TaiwanMarket cap $86 M (Nov 19, 2026)90 of 100 (industry or sector 50 + size 26 + country 15)+ Add
- Allied Biotech Corporation1780.TWO · 🇹🇼 TaiwanSame industry: Pharmaceutical · Similar size: $74 M market cap against $172 M · Same country: TaiwanMarket cap $74 M (Nov 19, 2026)90 of 100 (industry or sector 50 + size 25 + country 15)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.